GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,510,000 | +63.1% | 105,011 | -0.4% | 0.00% | +50.0% |
Q4 2020 | $1,539,000 | +2.8% | 105,390 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,497,000 | -0.4% | 105,390 | +3.2% | 0.00% | -33.3% |
Q2 2020 | $1,503,000 | +335.7% | 102,150 | +21.9% | 0.00% | +200.0% |
Q1 2020 | $345,000 | -17.3% | 83,771 | -3.3% | 0.00% | 0.0% |
Q4 2019 | $417,000 | -17.9% | 86,604 | +3.3% | 0.00% | 0.0% |
Q3 2019 | $508,000 | -6.6% | 83,831 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $544,000 | -3.4% | 83,831 | +5.6% | 0.00% | 0.0% |
Q1 2019 | $563,000 | +45.9% | 79,389 | +0.1% | 0.00% | 0.0% |
Q4 2018 | $386,000 | -33.8% | 79,339 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $583,000 | +15.9% | 79,339 | +0.7% | 0.00% | 0.0% |
Q2 2018 | $503,000 | +17.2% | 78,815 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $429,000 | +26.9% | 78,815 | -2.8% | 0.00% | 0.0% |
Q4 2017 | $338,000 | -56.7% | 81,096 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $781,000 | -15.1% | 81,096 | +4.3% | 0.00% | 0.0% |
Q2 2017 | $920,000 | -16.4% | 77,774 | -9.3% | 0.00% | 0.0% |
Q1 2017 | $1,100,000 | +0.1% | 85,774 | -4.5% | 0.00% | 0.0% |
Q4 2016 | $1,099,000 | +9.6% | 89,774 | +5.6% | 0.00% | 0.0% |
Q3 2016 | $1,003,000 | +37.0% | 84,974 | +1.0% | 0.00% | 0.0% |
Q2 2016 | $732,000 | +55.4% | 84,174 | -5.7% | 0.00% | +100.0% |
Q1 2016 | $471,000 | -22.3% | 89,284 | +14.3% | 0.00% | 0.0% |
Q4 2015 | $606,000 | +0.5% | 78,138 | +1.9% | 0.00% | -50.0% |
Q3 2015 | $603,000 | -13.5% | 76,661 | -0.4% | 0.00% | 0.0% |
Q2 2015 | $697,000 | -29.3% | 76,961 | +1.3% | 0.00% | 0.0% |
Q1 2015 | $986,000 | -6.0% | 75,999 | -1.4% | 0.00% | 0.0% |
Q4 2014 | $1,049,000 | +52.2% | 77,099 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $689,000 | -32.9% | 76,771 | +1.1% | 0.00% | -33.3% |
Q2 2014 | $1,027,000 | +59.5% | 75,935 | +17.1% | 0.00% | +50.0% |
Q1 2014 | $644,000 | -25.4% | 64,835 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $863,000 | +10.8% | 64,835 | +1.1% | 0.00% | 0.0% |
Q3 2013 | $779,000 | +48.4% | 64,135 | +26.4% | 0.00% | 0.0% |
Q2 2013 | $525,000 | – | 50,735 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |